SmartKem, Inc. heads into its May 15 earnings event with a short-selling wave crashing into a stock that has just rallied 37% in a week.
The headline tension here is impossible to ignore. Short interest has exploded 368% over the past week to 9.5% of the free float — the steepest single-week surge on record for this stock. At the start of May, SMTK had barely 30,000-odd shares short. By May 7, that figure had jumped to nearly 585,000. The catalyst is a prospectus filed on April 17, disclosing a plan to sell up to 146.8 million shares to Keystone Capital Partners. That pending dilution — enormous relative to SMTK's micro-cap size — lit the fuse. Shorts clearly read the filing and moved fast.
What makes the positioning picture more charged is how quickly the borrow market has tightened. Availability has dropped to roughly 36% of outstanding short interest, meaning there are only about one share still available to borrow for every three already lent out. That's a firm signal the lending pool is under strain, especially given the pace at which new shorts have been added. Cost to borrow is running near 11.8% annualised — off its March peak above 18% but still elevated, reflecting genuine demand for the name. The ORTEX short score has climbed to 55, up from 35 just two weeks ago, as all three borrow dimensions tightened together.
The fundamental picture is thin, which makes the dilution risk the main story the Street is watching. SMTK's enterprise value sits below $3 million, and institutional ownership is fragmented — Aigh Capital Management holds the largest disclosed stake at 3.2% of shares, with no recent change. Five Narrow Lane trimmed its position by 123,000 shares through year-end. There are no analyst ratings or price targets in the data. For a stock trading at $0.32, the Nasdaq delisting notice filed on April 23 adds another layer of pressure that fundamental buyers would need to look through.
Recent price-reaction history offers a sharp contrast of regimes. The April 8 event produced a one-day gain of 46% and a five-day gain of 40%. The March 27 earnings event, however, saw a one-day drop of 8.4%, recovering modestly to +4% over five days. With the next event confirmed for May 15, those two prior reactions sit at opposite ends of the spectrum — making the outcome especially hard to handicap.
The note to watch into May 15 is whether the Keystone dilution overhang resolves, accelerates, or gets revised — because the answer to that question, more than anything in the earnings release itself, is what will determine whether the short interest already built this week covers quickly or grows further.
See the live data behind this article on ORTEX.
Open SMTK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
